Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Intravenous Thrombolysis in Expanded Time Window (3-4.5 hours) in General Practice with Concurrent Availability of Endovascular Treatment.

Tekle WG, Chaudhry SA, Fatima Z, Ahmed M, Khalil S, Hassan AE, Rodriguez GJ, Suri FK, Qureshi AI.

J Vasc Interv Neurol. 2012 Jun;5(1):22-6.

2.

Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.

Tekle WG, Chaudhry SA, Hassan AE, Peacock JM, Lakshminarayan K, Tsai A, Luepker R, Anderson DC, Qureshi AI.

Cerebrovasc Dis. 2012;34(5-6):400-5. doi: 10.1159/000343504. Epub 2012 Dec 4.

PMID:
23221276
4.

Feasibility and outcomes of intravenous thrombolysis 3-4.5 hours after stroke in Chinese patients.

Xu ZP, Li HH, Li YH, Zhang Y, Wu Q, Lin L.

J Clin Neurosci. 2014 May;21(5):822-6. doi: 10.1016/j.jocn.2013.08.014. Epub 2013 Oct 19.

PMID:
24444672
5.

Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.

Mathews MS, Sharma J, Snyder KV, Natarajan SK, Siddiqui AH, Hopkins LN, Levy EI.

Neurosurgery. 2009 Nov;65(5):860-5; discussion 865. doi: 10.1227/01.NEU.0000358953.19069.E5.

PMID:
19834397
6.

Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?

Hassan AE, Zacharatos H, Hassanzadeh B, El-Gengaihy A, AlKawi A, Shhadeh A, Kirmani JF.

J Stroke Cerebrovasc Dis. 2010 Mar;19(2):116-20. doi: 10.1016/j.jstrokecerebrovasdis.2009.03.019.

PMID:
20189087
7.

Comparison of time to treatment between intravenous and endovascular thrombolytic treatments for acute ischemic stroke.

Asaithambi G, Hassan AE, Chaudhry SA, Rodriguez GJ, Suri MF, Taylor RA, Ezzeddine MA, Qureshi AI.

J Vasc Interv Neurol. 2011 Jul;4(2):15-20.

8.

Rescue Thrombectomy in Large Vessel Occlusion Strokes Leads to Better Outcomes than Intravenous Thrombolysis Alone: A 'Real World' Applicability of the Recent Trials.

Nogueira RG, Zaidat OO, Castonguay AC, Haussen DC, Martin CO, Holloway WE, Mueller-Kronast N, English J, Linfante I, Dabus G, Malisch TW, Marden FA, Bozorgchami H, Xavier A, Rai AT, Froehler MT, Badruddin A, Nguyen TN, Taqi MA, Abraham MG, Janardhan V, Yoo AJ, Shaltoni H, Abou-Chebl A, Chen PR, Britz GW, Novakovic R, Nanda A, Kaushal R, Issa MA, Frankel MR, Gupta R.

Interv Neurol. 2016 Sep;5(3-4):101-110. Epub 2016 May 27.

10.

Very mild stroke patients benefit from intravenous tissue plasminogen activator without increase of intracranial hemorrhage.

Hassan AE, Hassanzadeh B, Tohidi V, Kirmani JF.

South Med J. 2010 May;103(5):398-402. doi: 10.1097/SMJ.0b013e3181d7814a.

PMID:
20375952
11.

Eligibility determination for intravenous thrombolysis based on radiology interpretation report of the head CT scan in patients with acute ischemic stroke.

Hassan AE, Majidi S, Janjua NA, Chaudhry SA, Tekle WG, Grigoryan M, Qureshi AI.

J Neuroimaging. 2014 Jul-Aug;24(4):349-53. doi: 10.1111/jon.12045. Epub 2013 Sep 9.

PMID:
24015702
12.

Intraarterial thrombolytic therapy within 3 hours of the onset of stroke.

Bourekas EC, Slivka AP, Shah R, Sunshine J, Suarez JI.

Neurosurgery. 2004 Jan;54(1):39-44; discussion 44-6.

PMID:
14683539
13.

[Prospects of thrombolytic therapy for acute ischemic stroke].

Nakashima T, Minematsu K.

Brain Nerve. 2009 Sep;61(9):1003-12. Review. Japanese.

PMID:
19803399
14.

Outcome of the 'Drip-and-Ship' Paradigm among Patients with Acute Ischemic Stroke: Results of a Statewide Study.

Qureshi AI, Chaudhry SA, Rodriguez GJ, Suri MF, Lakshminarayan K, Ezzeddine MA.

Cerebrovasc Dis Extra. 2012 Winter;2(1):1-8.

15.

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH, et al.

JAMA. 1995 Oct 4;274(13):1017-25.

PMID:
7563451
16.

Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation.

Lawson TR, Brown IE, Westerkam DL, Blackhurst DW, Sternberg S, Leacock R, Nathaniel TI.

Restor Neurol Neurosci. 2015;33(3):301-8. doi: 10.3233/RNN-140480.

PMID:
25698111
17.

Early neurologic improvement based on the National Institutes of Health Stroke Scale score predicts favorable outcome within 30 minutes after undergoing intravenous recombinant tissue plasminogen activator therapy.

Takagi T, Kato T, Sakai H, Nishimura Y.

J Stroke Cerebrovasc Dis. 2014 Jan;23(1):69-74. doi: 10.1016/j.jstrokecerebrovasdis.2012.09.013. Epub 2012 Nov 16.

PMID:
23164483
18.

Adherence to guidelines by emergency medical services during transport of stroke patients receiving intravenous thrombolytic infusion.

Asaithambi G, Chaudhry SA, Hassan AE, Rodriguez GJ, Suri MF, Qureshi AI.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e42-5. doi: 10.1016/j.jstrokecerebrovasdis.2012.03.018. Epub 2012 May 8.

PMID:
22572162
19.

Acute stroke reperfusion therapy trends in the expanded treatment window era.

Asaithambi G, Tong X, George MG, Tsai AW, Peacock JM, Luepker RV, Lakshminarayan K.

J Stroke Cerebrovasc Dis. 2014 Oct;23(9):2316-21. doi: 10.1016/j.jstrokecerebrovasdis.2014.04.023. Epub 2014 Aug 23.

20.

Comparison of acute nonthrombolytic and thrombolytic treatments in ischemic stroke patients 80 years or older.

Zacharatos H, Hassan AE, Vazquez G, Hussein HM, Rodriguez GJ, Suri MF, Lakshminarayan K, Ezzeddine MA, Qureshi AI.

Am J Emerg Med. 2012 Jan;30(1):158-64. doi: 10.1016/j.ajem.2010.11.019. Epub 2011 Jan 17.

PMID:
21247724

Supplemental Content

Support Center